Specialists awarded $4M grant for diabetes research

Albert Einstein College of Medicine in New York City has received a five-year, $4 million grant from the National Institutes of Health (NIH) to back the New York Regional Center for Diabetes Translation Research (NY-CDTR).

The NY-CDTR encourages collaboration and research on strategies designed to improve diabetes prevention, care, and self-management, with a focus on health equity.

“Our center is in a unique position, both geographically and due to our expertise—to support investigators who are conducting research aimed at helping those who shoulder the greatest burden of diabetes in the U.S.—namely people of color and those with lower socio-economic status,” said Jeffrey Gonzalez, PhD,  principal investigator on the grant and director of the NY-CDTR, in a press release. “We will prioritize studies aimed at reducing health inequities and developing interventions that can be implemented under real world conditions and in diverse healthcare and community locations.”

This new funding is expected to go toward the center’s operations, including behavioral science and technology cores that are studying how telehealth, smartphone apps, continuous glucose monitoring devices and other technologies can be used to manage diabetes.

Around the web

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.

The imaging manufacturer expects to spend between $227 million and $340 million on tariff mitigation efforts, leaders said Wednesday.